LIN28B and hepatocellular carcinoma: Similarly, transgenic mice overexpressing LIN28B in the liver develop hepatic cancer with higher glucose consumption compared to the surrounding normal tissue, mirroring the behavior of a subset of aggressive human hepatocellular carcinomas [17].